Cite
HARVARD Citation
Conte, P. et al. (2018). Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡. Annals of oncology. pp. 2328-2333. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Conte, P. et al. (2018). Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡. Annals of oncology. pp. 2328-2333. [Online].